Announcement • Jul 28
Paramount Cosmetics (India) Limited to Report Q1, 2027 Results on Aug 12, 2026 Paramount Cosmetics (India) Limited announced that they will report Q1, 2027 results on Aug 12, 2026 New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 45% per year over the past 5 years. Market cap is less than US$10m (₹165.1m market cap, or US$1.71m). Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Revenue is less than US$5m (₹214m revenue, or US$2.2m). Announcement • Jun 18
Paramount Cosmetics (India) Limited Announces Appointment of Prerna Jain as Whole-Time Company Secretary and Compliance Officer, Effective June 18, 2026 Paramount Cosmetics (India) Limited held its Board of Directors meeting on June 18, 2026 and considered and approved the appointment of Ms. Prerna Jain as Whole-Time Company Secretary and Compliance Officer of the Company on recommendation of Nomination and Remuneration committee with effect from June 18, 2026. Ms. Prerna Jain is an Associate Member of the Institute of Company Secretaries of India and having experience in the areas of corporate laws, secretarial compliance, corporate governance, regulatory affairs, and capital market regulations. She possesses extensive experience in handling compliance and regulatory matters pertaining to listed companies, including compliance with the provisions of the Companies Act, SEBI regulations, and corporate governance requirements. Her expertise encompasses SEBI (Listing Obligations and Disclosure Requirements) Regulations, ICDR Regulations, SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, SEBI (Prohibition of Insider Trading) Regulations, board and committee matters, investor relations, statutory filings, and regulatory reporting. She has also gained valuable exposure in the field of due diligence, regulatory compliance, documentation, and coordination in relation to public issues, rights issues, preferential issues, private placements, and other capital market transactions. She has experience in dealing with various intermediaries, stock exchanges, and regulatory authorities in connection with such assignments. Her professional expertise, sound knowledge of corporate and securities laws, and commitment to high standards of governance and compliance make her well-suited for the responsibilities entrusted to her. New Risk • May 11
New major risk - Revenue and earnings growth Earnings have declined by 45% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 45% per year over the past 5 years. Market cap is less than US$10m (₹177.1m market cap, or US$1.86m). Minor Risk Revenue is less than US$5m (₹225m revenue, or US$2.4m). Reported Earnings • May 11
Full year 2026 earnings released: EPS: ₹0.11 (vs ₹0.062 in FY 2025) Full year 2026 results: EPS: ₹0.11 (up from ₹0.062 in FY 2025). Revenue: ₹225.0m (up 10% from FY 2025). Net income: ₹512.0k (up 71% from FY 2025). Profit margin: 0.2% (up from 0.1% in FY 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 49% per year but the company’s share price has remained flat, which means it is well ahead of earnings. Announcement • May 04
Paramount Cosmetics (India) Limited to Report Q4, 2026 Results on May 08, 2026 Paramount Cosmetics (India) Limited announced that they will report Q4, 2026 results on May 08, 2026 Reported Earnings • Feb 10
Third quarter 2026 earnings released Third quarter 2026 results: EPS: ₹0.28. Revenue: ₹54.7m (down 1.5% from 3Q 2025). Net income: ₹342.0k (up 62% from 3Q 2025). Profit margin: 0.6% (up from 0.4% in 3Q 2025). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Announcement • Feb 03
Paramount Cosmetics (India) Limited to Report Q3, 2026 Results on Feb 09, 2026 Paramount Cosmetics (India) Limited announced that they will report Q3, 2026 results at 12:15 PM, Indian Standard Time on Feb 09, 2026 Reported Earnings • Nov 10
Second quarter 2026 earnings released Second quarter 2026 results: EPS: ₹0.95. Revenue: ₹89.2m (up 74% from 2Q 2025). Net income: ₹1.15m (up ₹1.02m from 2Q 2025). Profit margin: 1.3% (up from 0.3% in 2Q 2025). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • Oct 31
Paramount Cosmetics (India) Limited to Report Q2, 2026 Results on Nov 07, 2025 Paramount Cosmetics (India) Limited announced that they will report Q2, 2026 results on Nov 07, 2025 Buy Or Sell Opportunity • Oct 09
Now 25% overvalued after recent price rise Over the last 90 days, the stock has risen 6.5% to ₹41.75. The fair value is estimated to be ₹33.44, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 8.3% over the last 3 years. Earnings per share has grown by 102%. Announcement • Sep 08
Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 30, 2025 Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 30, 2025, at 11:00 Indian Standard Time. Buy Or Sell Opportunity • Sep 05
Now 20% overvalued after recent price rise Over the last 90 days, the stock has risen 3.3% to ₹39.79. The fair value is estimated to be ₹33.06, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 8.3% over the last 3 years. Earnings per share has grown by 102%. Buy Or Sell Opportunity • Aug 19
Now 21% overvalued after recent price rise Over the last 90 days, the stock has risen 1.3% to ₹39.49. The fair value is estimated to be ₹32.73, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 8.3% over the last 3 years. Earnings per share has grown by 102%. Reported Earnings • Aug 16
First quarter 2026 earnings released First quarter 2026 results: ₹0.50 loss per share. Revenue: ₹50.3m (up 35% from 1Q 2025). Net loss: ₹605.0k (down ₹740.0k from profit in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings. Announcement • Aug 04
Paramount Cosmetics (India) Limited to Report Q1, 2026 Results on Aug 14, 2025 Paramount Cosmetics (India) Limited announced that they will report Q1, 2026 results on Aug 14, 2025 Reported Earnings • May 31
Full year 2025 earnings released: EPS: ₹0.06 (vs ₹0.044 in FY 2024) Full year 2025 results: EPS: ₹0.06 (up from ₹0.044 in FY 2024). Revenue: ₹216.1m (flat on FY 2024). Net income: ₹300.0k (up 40% from FY 2024). Profit margin: 0.1% (in line with FY 2024). Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Announcement • May 22
Paramount Cosmetics (India) Limited to Report Q4, 2025 Results on May 29, 2025 Paramount Cosmetics (India) Limited announced that they will report Q4, 2025 results on May 29, 2025 New Risk • Mar 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.5% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.2x net interest cover). Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 3.4% per year over the past 5 years. Market cap is less than US$10m (₹187.9m market cap, or US$2.15m). Minor Risk Revenue is less than US$5m (₹195m revenue, or US$2.2m). Reported Earnings • Feb 12
Third quarter 2025 earnings released: EPS: ₹0.17 (vs ₹0.06 in 3Q 2024) Third quarter 2025 results: EPS: ₹0.17. Revenue: ₹58.3m (down 7.1% from 3Q 2024). Net income: ₹211.0k (down 30% from 3Q 2024). Profit margin: 0.4% (down from 0.5% in 3Q 2024). Announcement • Feb 04
Paramount Cosmetics (India) Limited to Report Q3, 2025 Results on Feb 11, 2025 Paramount Cosmetics (India) Limited announced that they will report Q3, 2025 results on Feb 11, 2025 Reported Earnings • Nov 13
Second quarter 2025 earnings released Second quarter 2025 results: Revenue: ₹53.9m (down 5.6% from 2Q 2024). Net income: ₹137.0k (down 91% from 2Q 2024). Profit margin: 0.3% (down from 2.8% in 2Q 2024). Announcement • Oct 31
Paramount Cosmetics (India) Limited to Report Q2, 2025 Results on Nov 12, 2024 Paramount Cosmetics (India) Limited announced that they will report Q2, 2025 results on Nov 12, 2024 Announcement • Aug 23
Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 25, 2024 Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 25, 2024, at 11:00 Indian Standard Time. Reported Earnings • Aug 15
First quarter 2025 earnings released: EPS: ₹0.11 (vs ₹0.10 in 1Q 2024) First quarter 2025 results: EPS: ₹0.11. Revenue: ₹40.2m (down 15% from 1Q 2024). Net income: ₹135.0k (down 73% from 1Q 2024). Profit margin: 0.3% (down from 1.0% in 1Q 2024). The decrease in margin was driven by lower revenue. Announcement • Aug 02
Paramount Cosmetics (India) Limited to Report Q1, 2025 Results on Aug 13, 2024 Paramount Cosmetics (India) Limited announced that they will report Q1, 2025 results at 4:00 PM, Indian Standard Time on Aug 13, 2024 Reported Earnings • Jun 26
Full year 2024 earnings released: EPS: ₹0.04 (vs ₹0.44 in FY 2023) Full year 2024 results: EPS: ₹0.04 (down from ₹0.44 in FY 2023). Revenue: ₹238.6m (down 11% from FY 2023). Net income: ₹214.0k (down 90% from FY 2023). Profit margin: 0.1% (down from 0.8% in FY 2023). The decrease in margin was driven by lower revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance. New Risk • Jun 12
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.4x net interest cover). Market cap is less than US$10m (₹181.3m market cap, or US$2.17m). Minor Risks Share price has been volatile over the past 3 months (8.3% average weekly change). Revenue is less than US$5m (₹241m revenue, or US$2.9m). Announcement • May 18
Paramount Cosmetics (India) Limited to Report Q4, 2024 Results on May 23, 2024 Paramount Cosmetics (India) Limited announced that they will report Q4, 2024 results on May 23, 2024 Announcement • Mar 26
Paramount Cosmetics (India) Limited Appoints Ankita Karnani as Company Secretary and Compliance Officer Paramount Cosmetics (India) Limited at its board meeting held on March 26, 2024 appointed Ms. Ankita Karnani (Membership No. ACS 33634) as Company Secretary and Compliance Officer of the company with effect from March 26, 2024. Ms. Ankita Karnani is a qualified Company Secretary having Membership No. ACS 33634. She has more than 6 years of working experience in listed entities as Company Secretary. She has rich knowledge of Companies Act, 2013, Listing Regulations and has good post qualification experience in Secretarial field. She is an Associate member of the Institute of Company Secretaries of India and holds a bachelor's degree in commerce from Calcutta University. Reported Earnings • Feb 10
Third quarter 2024 earnings released: EPS: ₹0.06 (vs ₹0.04 in 3Q 2023) Third quarter 2024 results: EPS: ₹0.06 (up from ₹0.04 in 3Q 2023). Revenue: ₹66.0m (down 16% from 3Q 2023). Net income: ₹301.0k (up 43% from 3Q 2023). Profit margin: 0.5% (up from 0.3% in 3Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings. Announcement • Jan 26
Paramount Cosmetics (India) Limited to Report Q3, 2024 Results on Feb 09, 2024 Paramount Cosmetics (India) Limited announced that they will report Q3, 2024 results on Feb 09, 2024 Announcement • Jan 25
Paramount Cosmetics (India) Limited Announces Resignation of Mrs. Reshma M as Company Secretary and Compliance Officer Paramount Cosmetics (India) Limited announced the resignation of Mrs. Reshma M as Company Secretary and Compliance Officer, effective from January 25, 2024. Reason: She has decided to pursue her future endeavours. Reported Earnings • Nov 11
Second quarter 2024 earnings released: EPS: ₹0.33 (vs ₹0.21 in 2Q 2023) Second quarter 2024 results: EPS: ₹0.33 (up from ₹0.21 in 2Q 2023). Revenue: ₹69.4m (up 14% from 2Q 2023). Net income: ₹1.60m (up 60% from 2Q 2023). Profit margin: 2.3% (up from 1.6% in 2Q 2023). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has increased by 37% per year, which means it is well ahead of earnings. Announcement • Nov 04
Paramount Cosmetics (India) Limited to Report Q2, 2024 Results on Nov 09, 2023 Paramount Cosmetics (India) Limited announced that they will report Q2, 2024 results on Nov 09, 2023 Announcement • Sep 05
Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 29, 2023 Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 29, 2023, at 11:00 Indian Standard Time. Reported Earnings • Aug 12
First quarter 2024 earnings released: EPS: ₹0.10 (vs ₹0.09 in 1Q 2023) First quarter 2024 results: EPS: ₹0.10 (up from ₹0.09 in 1Q 2023). Revenue: ₹47.3m (down 11% from 1Q 2023). Net income: ₹493.0k (up 8.1% from 1Q 2023). Profit margin: 1.0% (up from 0.9% in 1Q 2023). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 4% per year but the company’s share price has increased by 33% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 04
Paramount Cosmetics (India) Limited to Report Q1, 2024 Results on Aug 11, 2023 Paramount Cosmetics (India) Limited announced that they will report Q1, 2024 results on Aug 11, 2023 Reported Earnings • Jun 04
Full year 2023 earnings released: EPS: ₹0.44 (vs ₹0.40 in FY 2022) Full year 2023 results: EPS: ₹0.44 (up from ₹0.40 in FY 2022). Revenue: ₹269.2m (up 33% from FY 2022). Net income: ₹2.12m (up 8.2% from FY 2022). Profit margin: 0.8% (down from 1.0% in FY 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. Announcement • May 31
Paramount Cosmetics (India) Limited Announces Appointment of Reshma M as Company Secretary and Compliance Officer Paramount Cosmetics (India) Limited announced that at its board meeting held on May 30, 2023, Based on the recommendation of Nomination and Remuneration Committee, appointed Mrs. Reshma M, as Company Secretary and Compliance Officer of the Company. Brief profile: Mrs. Reshma M, is a qualified Company Secretary and having membership No: A33180 and having academic qualification of B. Com from Seshadripuram College, Bangalore in the year 2006 and LLB from BES College of Law in the year 2021. She is having Seven years of experience in the field of Company Law, corporate Secretarial and FEMA matters. Date of appointment is May 30, 2023. Announcement • May 25
Paramount Cosmetics (India) Limited to Report Q4, 2023 Results on May 30, 2023 Paramount Cosmetics (India) Limited announced that they will report Q4, 2023 results on May 30, 2023 Announcement • Feb 03
Paramount Cosmetics (India) Limited to Report Q3, 2023 Results on Feb 13, 2023 Paramount Cosmetics (India) Limited announced that they will report Q3, 2023 results on Feb 13, 2023 Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 1 highly experienced director. Non-Executive & Non-Independent Director Aartii Topiwaala was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Announcement • Nov 15
Paramount Cosmetics (India) Limited Announces Board Changes Paramount Cosmetics (India) Limited announced that at its board meeting held on November 14, 2022 approved the reconstitution of the following committees of the Board. The board announced that the Audit committee: Vishwajeet Nalinkant Mehta as chairman, Vishwaskumar Sharma and Hiitesh Topiiwaalla as members. Nomination & Remuneration Committee: Vishwajeet Nalinkant Mehta as chairman, Vishwaskumar Sharma and Aartii Topiwaala as members. Announcement • Nov 09
Paramount Cosmetics (India) Limited Announces Resignation of Shishir B. Desai as Director Paramount Cosmetics (India) Limited announced that Mr. Shishir B. Desai vide his letter dated 04 November, 2022 and received on 08 November, 2022 tendered resignation from the position of Independent Director of the company with effect from 04 November, 2022 . Reason of Resignation: Due to personal and avoidable circumstances. There are no other reasons of resignation other than mentioned aforesaid. Announcement • Aug 25
Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 30, 2022 Paramount Cosmetics (India) Limited, Annual General Meeting, Sep 30, 2022, at 11:00 Indian Standard Time. Reported Earnings • Aug 12
First quarter 2023 earnings released: EPS: ₹0.09 (vs ₹2.68 in 1Q 2022) First quarter 2023 results: EPS: ₹0.09 (down from ₹2.68 in 1Q 2022). Revenue: ₹53.2m (up 143% from 1Q 2022). Net income: ₹456.0k (down 97% from 1Q 2022). Profit margin: 0.9% (down from 59% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has increased by 48% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 30
Full year 2022 earnings released: EPS: ₹0.40 (vs ₹0.71 in FY 2021) Full year 2022 results: EPS: ₹0.40 (down from ₹0.71 in FY 2021). Revenue: ₹247.5m (up 41% from FY 2021). Net income: ₹1.96m (down 43% from FY 2021). Profit margin: 0.8% (down from 2.0% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 53% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 26
Investor sentiment deteriorated over the past week After last week's 22% share price decline to ₹60.80, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 40x in the Personal Products industry in India. Total returns to shareholders of 270% over the past three years. Announcement • May 21
Paramount Cosmetics (India) Limited to Report Q4, 2022 Results on May 27, 2022 Paramount Cosmetics (India) Limited announced that they will report Q4, 2022 results on May 27, 2022 Buying Opportunity • May 11
Now 21% undervalued Over the last 90 days, the stock is up 145%. The fair value is estimated to be ₹111, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 10% over the last 3 years. Meanwhile, the company has become profitable. Valuation Update With 7 Day Price Move • Apr 29
Investor sentiment improved over the past week After last week's 27% share price gain to ₹125, the stock trades at a trailing P/E ratio of 15.8x. Average trailing P/E is 46x in the Personal Products industry in India. Total returns to shareholders of 632% over the past three years. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 2 highly experienced directors. Non-Executive & Non-Independent Director Aartii Topiwaala was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Insufficient board refreshment. Valuation Update With 7 Day Price Move • Apr 08
Investor sentiment improved over the past week After last week's 30% share price gain to ₹60.65, the stock trades at a trailing P/E ratio of 7.7x. Average trailing P/E is 45x in the Personal Products industry in India. Total returns to shareholders of 236% over the past three years. Reported Earnings • Feb 15
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹2.25 (up from ₹1.62 in 3Q 2021). Revenue: ₹68.8m (up 14% from 3Q 2021). Net income: ₹8.07m (up 2.5% from 3Q 2021). Profit margin: 12% (down from 13% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 90% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Feb 11
Investor sentiment improved over the past week After last week's 25% share price gain to ₹41.40, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 49x in the Personal Products industry in India. Total returns to shareholders of 100% over the past three years. Announcement • Feb 03
Paramount Cosmetics (India) Limited to Report Q3, 2022 Results on Feb 11, 2022 Paramount Cosmetics (India) Limited announced that they will report Q3, 2022 results on Feb 11, 2022 Valuation Update With 7 Day Price Move • Jan 26
Investor sentiment improved over the past week After last week's 18% share price gain to ₹36.55, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 44x in the Personal Products industry in India. Total returns to shareholders of 60% over the past three years. Valuation Update With 7 Day Price Move • Dec 13
Investor sentiment improved over the past week After last week's 21% share price gain to ₹32.45, the stock trades at a trailing P/E ratio of 5.5x. Average trailing P/E is 47x in the Personal Products industry in India. Total returns to shareholders of 20% over the past three years. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improved over the past week After last week's 17% share price gain to ₹24.95, the stock trades at a trailing P/E ratio of 35.1x. Average trailing P/E is 53x in the Personal Products industry in India. Total loss to shareholders of 23% over the past three years. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 17% share price gain to ₹22.75, the stock trades at a trailing P/E ratio of 32x. Average trailing P/E is 52x in the Personal Products industry in India. Total loss to shareholders of 25% over the past three years. Reported Earnings • Jul 06
Full year 2021 earnings released: EPS ₹0.71 (vs ₹0.24 loss in FY 2020) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2021 results: Revenue: ₹186.7m (down 23% from FY 2020). Net income: ₹3.43m (up ₹4.61m from FY 2020). Profit margin: 1.8% (up from net loss in FY 2020). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has only fallen by 9% per year, which means it has not declined as severely as earnings. Executive Departure • May 25
Company Secretary & Compliance Officer has left the company On the 13th of May, Santosh Shah's tenure as Company Secretary & Compliance Officer ended after less than a year in the role. We don't have any record of a personal shareholding under Santosh's name. Santosh is the only executive to leave the company over the last 12 months. Is New 90 Day High Low • Mar 05
New 90-day low: ₹15.00 The company is down 4.0% from its price of ₹15.60 on 04 December 2020. The Indian market is up 17% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Personal Products industry, which is up 3.0% over the same period. Is New 90 Day High Low • Dec 21
New 90-day high: ₹16.95 The company is up 19% from its price of ₹14.25 on 22 September 2020. The Indian market is up 20% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Personal Products industry, which is up 9.0% over the same period.